Estimating the transfusion transmission risk of Q fever

Transfusion

Volumn 54, Issue 7, 2014, Pages 1705-1711

  Oei, Welling ^a   Kretzschmar, Mirjam E E ^a,b   Zaaijer, Hans L ^c   Coutinho, Roel ^a,b   Van Der Poel, Cees L ^a   Janssen, Mart P ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c CENTRAL LABORATORY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD TRANSFUSION; CLINICAL ASSESSMENT TOOL; DISEASE TRANSMISSION; DONOR; EUROPEAN UP FRONT RISK ASSESSMENT TOOL; HUMAN; PATIENT SAFETY; Q FEVER; RECIPIENT; RISK ASSESSMENT; RISK REDUCTION; TRANSFUSION TRANSMISSION;

ADULT; AGED; BLOOD DONORS; BLOOD TRANSFUSION; COXIELLA BURNETII; DISEASE OUTBREAKS; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; Q FEVER; RISK; YOUNG ADULT;

EID: 84904468889     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12539     Document Type: Article

References (23)

1. van der Hoek W, Dijkstra F, Schimmer B, et al. Q fever in the Netherlands: an update on the epidemiology and control measures. Euro Surveill 2010; 15: pii=19520.
2. Schimmer B, Ter Schegget R, Wegdam M, et al. The use of a geographic information system to identify a dairy goat farm as the most likely source of an urban Q-fever outbreak. BMC Infect Dis 2010; 10: 69.
3. Hogema BM, Slot E, Molier M, et al. Coxiella burnetii infection among blood donors during the 2009 Q-fever outbreak in The Netherlands. Transfusion 2012; 52: 144-150.
4. CDC. Q fever transmitted by blood transfusion-United States. Veterinary Public Health Notes 1977.
5. Maurin M, Raoult D,. Q fever. Clin Microbiol Rev 1999; 12: 518-553.
6. Biggerstaff BJ, Petersen LR,. Estimated risk of transmission of the West Nile virus through blood transfusion in the US, 2002. Transfusion 2003; 43: 1007-1017.
7. Liumbruno GM, Calteri D, Petropulacos K, et al. The Chikungunya epidemic in Italy and its repercussion on the blood system. Blood Transfus 2008; 6: 199-210.
8. Kleinman S, Cameron C, Custer B, et al. Modeling the risk of an emerging pathogen entering the Canadian blood supply. Transfusion 2010; 50: 2592-2606.
9. Oei W, Janssen MP, van der Poel CL, et al. Modeling the transmission risk of emerging infectious diseases through blood transfusion. Transfusion 2013; 53: 1421-1428.
10. Dijkstra F, van der Hoek W, Wijers N, et al. The 2007-2010 Q fever epidemic in The Netherlands: characteristics of notified acute Q fever patients and the association with dairy goat farming. FEMS Immunol Med Microbiol 2012; 64: 3-12.
11. van der Hoek W, Hogema BM, Dijkstra F, et al. Relation between Q fever notifications and Coxiella burnetii infections during the 2009 outbreak in The Netherlands. Euro Surveill 2012; 17: pii=20058.
12. Centre of Statistics Bureau. Statistics Netherlands. Bevolking en huishoudens; viercijverige postcode, 1 january 2010. [Population and households; four-digits postcode, 1 January 2010]. 2012. The Hague. 7-1-2012.
13. Raoult D, Tissot-Dupont H, Foucault C, et al. Q fever 1985-1998. Clinical and epidemiologic features of 1,383 infections. Medicine (Baltimore) 2000; 79: 109-123.
14. European Centre for Disease Prevention and Control (ECDC). ECDC Technical report-risk assessment on Q fever. Stockholm: ECDC; 2010.
15. Morroy G, Peters JB, van Nieuwenhof M, et al. The health status of Q-fever patients after long-term follow-up. BMC Infect Dis 2011; 11: 97.
16. van der Hoek W, Versteeg B, Meekelenkamp JC, et al. Follow-up of 686 patients with acute Q fever and detection of chronic infection. Clin Infect Dis 2011; 52: 1431-1436.
17. McDonald S, Brooke J, National Institute for Public Health and the Environment (RIVM). Disease specific information: Q fever. 1-20. 9-28- 2011. Report.
18. Fournier PE, Raoult D,. Comparison of PCR and serology assays for early diagnosis of acute Q fever. J Clin Microbiol 2003; 41: 5094-5098.
19. Schneeberger PM, Hermans MH, van Hannen EJ, et al. Real-time PCR with serum samples is indispensable for early diagnosis of acute Q fever. Clin Vaccine Immunol 2010; 17: 286-290.
20. Kampschreur LM, Dekker S, Hagenaars JC, et al. Identification of risk factors for chronic Q fever, the Netherlands. Emerg Infect Dis 2012; 18: 563-570.
21. ECDC. Commission Directive 2004/33/EC of 22 March 2004 implementing Directive 2002/98/EC of the European Parliament and of the Council as regards certain technical requirements for blood and blood components. OJ L 91, 30.3. 2004, p. 25-39. 3-30-2004.
22. Slot E, Hogema BM, Molier M, et al. Screening of blood donors for chronic Coxiella burnetii infection after large Q fever outbreaks. Transfusion. In press 2014.
23. van Kraaij MG, Slot E, Hogema BM, et al. Lookback procedures after postdonation notifications during a Q fever outbreak in the Netherlands. Transfusion 2013; 53: 716-721.